BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15644479)

  • 1. Promethazine adverse events after implementation of a medication shortage interchange.
    Sheth HS; Verrico MM; Skledar SJ; Towers AL
    Ann Pharmacother; 2005 Feb; 39(2):255-61. PubMed ID: 15644479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: Promethazine adverse events after implementation of a medication shortage interchange.
    Habib AS; Breen TW; Gan TJ
    Ann Pharmacother; 2005; 39(7-8):1370; author reply 1370-1. PubMed ID: 15956221
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
    Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
    Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants.
    Zaidenstein R; Eyal S; Efrati S; Akivison L; Michowitz MK; Nagornov V; Golik A
    Pharmacoepidemiol Drug Saf; 2002; 11(3):235-8. PubMed ID: 12051123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
    Oderda GM; Said Q; Evans RS; Stoddard GJ; Lloyd J; Jackson K; Rublee D; Samore MH
    Ann Pharmacother; 2007 Mar; 41(3):400-6. PubMed ID: 17341537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication reconciliation for reducing drug-discrepancy adverse events.
    Boockvar KS; Carlson LaCorte H; Giambanco V; Fridman B; Siu A
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):236-43. PubMed ID: 17062324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events in trauma patients.
    Lazarus HM; Fox J; Evans RS; Lloyd JF; Pombo DJ; Burke JP; Handrahan D; Egger MJ; Allen TL; Stevens MH
    J Trauma; 2003 Feb; 54(2):337-43. PubMed ID: 12579062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug events in adult patients leading to emergency department visits.
    Sikdar KC; Alaghehbandan R; MacDonald D; Barrett B; Collins KD; Donnan J; Gadag V
    Ann Pharmacother; 2010 Apr; 44(4):641-9. PubMed ID: 20233911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients.
    Ajuoga E; Sansgiry SS; Ngo C; Yeh RF
    Res Social Adm Pharm; 2008 Sep; 4(3):292-301. PubMed ID: 18794039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit.
    Buckley MS; Erstad BL; Kopp BJ; Theodorou AA; Priestley G
    Pediatr Crit Care Med; 2007 Mar; 8(2):145-52. PubMed ID: 17273111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of adverse drug events in a highly computerized hospital.
    Nebeker JR; Hoffman JM; Weir CR; Bennett CL; Hurdle JF
    Arch Intern Med; 2005 May; 165(10):1111-6. PubMed ID: 15911723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
    Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department.
    Phan H; Leder M; Fishley M; Moeller M; Nahata M
    Pediatr Emerg Care; 2010 Jun; 26(6):424-30. PubMed ID: 20502385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
    Habib AS; Gan TJ
    J Clin Anesth; 2005 Feb; 17(1):62-5. PubMed ID: 15721732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for self-reported adverse drug events among Medicare enrollees.
    Oladimeji O; Farris KB; Urmie JG; Doucette WR
    Ann Pharmacother; 2008 Jan; 42(1):53-61. PubMed ID: 18029427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can an algorithm for appropriate prescribing predict adverse drug events?
    Rask KJ; Wells KJ; Teitel GS; Hawley JN; Richards C; Gazmararian JA
    Am J Manag Care; 2005 Mar; 11(3):145-51. PubMed ID: 15786853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug events in hospitalized cardiac patients.
    Fanikos J; Cina JL; Baroletti S; Fiumara K; Matta L; Goldhaber SZ
    Am J Cardiol; 2007 Nov; 100(9):1465-9. PubMed ID: 17950809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
    Al-Tajir GK; Kelly WN
    Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.